Latest Lyrica news
Downstream Harms of Gabapentinoid-Diuretic Prescribing Cascade Often Overlooked
posted December 9th
by modernClinician Editorial Team
by modernClinician Editorial Team
FDA Grants First Approvals for Generic Versions of Lyrica
posted July 22nd
by modernClinician Editorial Team
by modernClinician Editorial Team
Nine drug companies have received approval for the first generic versions of Lyrica (pregabalin), the U.S. Food and Drug Administration announced today.
Odds of Death Up With Exposure to Pregabalin, Opioids
posted August 20th
by modernClinician Editorial Team
by modernClinician Editorial Team
Concomitant exposure to pregabalin and opioids is associated with increased odds of opioid-related death, according to a research letter published online Aug. 21 in the Annals of Internal Medicine.
Pregabalin Doesn’t Cut Intensity of Sciatica-Linked Leg Pain
posted March 22nd
by modernClinician Editorial Team
by modernClinician Editorial Team
Pregabalin does not significantly reduce the intensity of leg pain associated with sciatica, according to a study published in the March 23 issue of the New England Journal of Medicine.
Acupuncture Reduces Pain With Chronic Sciatica From Herniated Disk 
Early Physical Therapy Beneficial for Acute Back Pain With Sciatica 
Pregabalin Benefits Not Linked to Prior Gabapentin Use 
Pregabalin in Pregnancy Linked to Increased Risk of Birth Defects Monthly Specialist Briefings
Stay Connected
